Back to Search Start Over

A review on the traditional uses, phytochemistry, and pharmacological activities of clove basil ( Ocimum gratissimum L.).

Authors :
Ugbogu OC
Emmanuel O
Agi GO
Ibe C
Ekweogu CN
Ude VC
Uche ME
Nnanna RO
Ugbogu EA
Source :
Heliyon [Heliyon] 2021 Nov 25; Vol. 7 (11), pp. e08404. Date of Electronic Publication: 2021 Nov 25 (Print Publication: 2021).
Publication Year :
2021

Abstract

In traditional medicine, Ocimum gratissimum (clove basil) is used in the treatment of various diseases such as diabetes, cancer, inflammation, anaemia, diarrhoea, pains, and fungal and bacterial infections. The present study reviewed the phytochemicals, essential oils, and pharmacological activities of O. gratissimum . The bioactive compounds extracted from O. gratissimum include phytochemicals (oleanolic acid, caffeic acid, ellagic acid, epicatechin, sinapic acid, rosmarinic acid, chlorogenic acid, luteolin, apigenin, nepetoidin, xanthomicrol, nevadensin, salvigenin, gallic acid, catechin, quercetin, rutin, and kaempfero) and essential oils (camphene, β-caryophyllene, α- and β-pinene, α-humulene, sabinene, β-myrcene, limonene, 1,8-cineole, trans-β-ocimene, linalool, α- and δ-terpineol, eugenol, α-copaene, β-elemene, p-cymene, thymol, and carvacrol). Various in vivo and in vitro studies have shown that O. gratissimum and its bioactive constituents possess pharmacological properties such as antioxidant, anti-inflammatory, anticancer, hepatoprotective, antidiabetic, antihypertensive, antidiarrhoeal, and antimicrobial properties. This review demonstrated that O. gratissimum has a strong preventive and therapeutic effect against several diseases. The effectiveness of O. gratissimum to ameliorate various diseases may be attributed to its antimicrobial and antioxidant properties as well as its capacity to improve the antioxidant systems. However, despite the widespread pharmacological activities of O. gratissimum , further experiments in human clinical trial studies are needed to establish effective and safe doses for the treatment of various diseases.<br />Competing Interests: The authors declare no conflict of interest.<br /> (© 2021 The Author(s).)

Details

Language :
English
ISSN :
2405-8440
Volume :
7
Issue :
11
Database :
MEDLINE
Journal :
Heliyon
Publication Type :
Academic Journal
Accession number :
34901489
Full Text :
https://doi.org/10.1016/j.heliyon.2021.e08404